T h e r a p e u t i c I n d e x 63 Clinical Pharmacology Evecare has potent phytoestrogenic, gonadotropin-agonist, antihemorrhagic, antimicrobial, anti-inflammatory and analgesic, antispasmodic, antioxidant, and adaptogenic actions. Evecare has a regularizing influence on the menstrual cycle by virtue of its uterine-stimulant action. The stimulatory effect of Evecare on the ovarian tissue helps regularize endogenous hormonal secretion, enhances the repair of the endometrium, and thus controls abnormal uterine bleeding. The anti-inflammatory action of Evecare has a healing effect on the uterus, and its antispasmodic action alleviates pain. The hematinic properties of Evecare are beneficial in anemia and generalized weakness associated with uterine disorders. Indications • Menstrual irregularities: – Dysfunctional uterine bleeding (DUB)—Menorrhagia, Metrorrhagia – Oligomenorrhea • Dysmenorrhea • Premenstrual syndrome (PMS) • Polycystic ovarian syndrome (PCOS) • Assisted conception Dosage PMS/Dysmenorrhea/Menstrual irregularities/DUB: Capsule: 1 capsule twice daily. In severe cases, 2 capsules twice daily. Syrup: 2 to 3 teaspoonsful (10 to 15 mL) twice daily. Treatment should be continued for a minimum of 3 months. Assisted conception: Capsule: 2 capsules twice daily. Syrup: 2 teaspoonsful (10 mL) twice daily. Adverse Effects No adverse effects have been reported. Contraindications No known contraindications. Special Precautions • Should not be used in patients with estrogen-dependent tumors. • Severe dysmenorrhea or uncontrolled DUB may require additional investigations. Drug Interactions No clinically significant drug interactions have been reported. Presentation Capsule: Sealed pack of 30 capsules. Syrup: Pilfer-proof bottles of 200 mL and 400 mL with measuring cups. Evecare® (capsule, syrup)
RkJQdWJsaXNoZXIy MjMwNjM2Nw==